Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Chaisson

Showing results (201-210 of 241) with videos related to

Pageof 25
Sort By:
AIDS Research and Human Retroviruses|October 9, 2010
Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, BrazilAntonio G Pacheco, Valeria Saraceni, Suely H Tuboi, et al.
BMJ Global Health|May 24, 2022
First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in IndiaTenzin Tsundue, Tenzin Namdon, Tenzin Tsewang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 15, 2014
Preventing tuberculosis among HIV-infected pregnant women in Lesotho: the case for rolling out active case finding and isoniazid preventive therapyAppolinaire Tiam, Rhoderick Machekano, Celine R Gounder, et al.
Plos Medicine|January 19, 2021
Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessmentKunchok Dorjee, Sonam Topgyal, Tenzin Tsewang, et al.
PLOS Global Public Health|April 30, 2025
Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB)Akash Malhotra, Ahmed Bedru, Fiseha Mulatu, et al.
AIDS Research and Human Retroviruses|September 1, 2021
The Mid-Atlantic Centers for AIDS Research Consortium: Promoting HIV Science Through Regional CollaborationAlan E Greenberg, David D Celentano, David S Metzger, et al.
The Lancet. Respiratory Medicine|March 26, 2023
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysisNicholas Winters, Robert Belknap, Andrea Benedetti, et al.
The Lancet. HIV|May 11, 2025
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trialEthel D Weld, Trevor Beattie, Jayajothi Moodley, et al.
Vaccine|April 28, 2024
Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in IndiaKunchok Dorjee, Tenzin Namdon, Sonam Topgyal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee ChildrenKunchok Dorjee, Sonam Topgyal, Chungdak Dorjee, et al.
Pageof 25

Showing results (201-210 of 241) with videos related to

Sort By:
Pageof 25
AIDS Research and Human Retroviruses|October 9, 2010
Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, BrazilAntonio G Pacheco, Valeria Saraceni, Suely H Tuboi, et al.
BMJ Global Health|May 24, 2022
First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in IndiaTenzin Tsundue, Tenzin Namdon, Tenzin Tsewang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 15, 2014
Preventing tuberculosis among HIV-infected pregnant women in Lesotho: the case for rolling out active case finding and isoniazid preventive therapyAppolinaire Tiam, Rhoderick Machekano, Celine R Gounder, et al.
Plos Medicine|January 19, 2021
Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessmentKunchok Dorjee, Sonam Topgyal, Tenzin Tsewang, et al.
PLOS Global Public Health|April 30, 2025
Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB)Akash Malhotra, Ahmed Bedru, Fiseha Mulatu, et al.
AIDS Research and Human Retroviruses|September 1, 2021
The Mid-Atlantic Centers for AIDS Research Consortium: Promoting HIV Science Through Regional CollaborationAlan E Greenberg, David D Celentano, David S Metzger, et al.
The Lancet. Respiratory Medicine|March 26, 2023
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysisNicholas Winters, Robert Belknap, Andrea Benedetti, et al.
The Lancet. HIV|May 11, 2025
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trialEthel D Weld, Trevor Beattie, Jayajothi Moodley, et al.
Vaccine|April 28, 2024
Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in IndiaKunchok Dorjee, Tenzin Namdon, Sonam Topgyal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee ChildrenKunchok Dorjee, Sonam Topgyal, Chungdak Dorjee, et al.
Pageof 25